HomeCompareLYSFF vs MRK

LYSFF vs MRK: Dividend Comparison 2026

LYSFF yields 4.72% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 LYSFF wins by $9.45M in total portfolio value
10 years
LYSFF
LYSFF
● Live price
4.72%
Share price
$5.19
Annual div
$0.24
5Y div CAGR
67.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$9.50M
Annual income
$7,674,961.04
Full LYSFF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — LYSFF vs MRK

📍 LYSFF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodLYSFFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, LYSFF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
LYSFF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LYSFF
Annual income on $10K today (after 15% tax)
$401.20/yr
After 10yr DRIP, annual income (after tax)
$6,523,716.88/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, LYSFF beats the other by $6,515,120.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LYSFF + MRK for your $10,000?

LYSFF: 50%MRK: 50%
100% MRK50/50100% LYSFF
Portfolio after 10yr
$4.78M
Annual income
$3,842,537.41/yr
Blended yield
80.37%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LYSFF
No analyst data
Altman Z
2.5
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LYSFF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricLYSFFMRK
Forward yield4.72%2.81%
Annual dividend / share$0.24$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR67.6%32.7%
Portfolio after 10y$9.50M$57.7K
Annual income after 10y$7,674,961.04$10,113.78
Total dividends collected$9.32M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: LYSFF vs MRK ($10,000, DRIP)

YearLYSFF PortfolioLYSFF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,491$791.07$11,213$373.04+$278.00LYSFF
2$13,719$1,423.85$12,667$512.06+$1.1KLYSFF
3$17,342$2,662.71$14,439$708.14+$2.9KLYSFF
4$23,829$5,272.19$16,640$988.16+$7.2KLYSFF
5$36,843$11,346.72$19,432$1,394.07+$17.4KLYSFF
6$66,903$27,480.28$23,057$1,992.90+$43.8KLYSFF
7$149,748$78,162.13$27,889$2,894.79+$121.9KLYSFF
8$434,264$274,034.13$34,518$4,286.29+$399.7KLYSFF
9$1,709,431$1,244,768.23$43,912$6,494.35+$1.67MLYSFF
10$9,504,052$7,674,961.04$57,714$10,113.78+$9.45MLYSFF

LYSFF vs MRK: Complete Analysis 2026

LYSFFStock

Lerøy Seafood Group ASA produces, processes, markets, sells, and distributes seafood products worldwide. It operates in three segments: Wildcatch; Farming; and Value-Added Processing, Sales and Distribution. The company offers smoked and gravad salmon, and trout products; farmed and wild catch whole fishes; fillets and portions; ready to eat and ready to cook products; fish blocks and cubes; breaded products; pre-fried fish burgers and patties; crustaceans and molluscs; seaweeds; and other products. Lerøy Seafood Group ASA markets its products primarily under the Norway Seafoods, Arctic Supreme, Fjord trout, Aurora Salmon, Fossen, Sea Eagle, Lerøy, and M?r brands to shops, restaurants, canteens, and hotels. The company was founded in 1899 and is headquartered in Bergen, Norway. Lerøy Seafood Group ASA is a subsidiary of Austevoll Seafood ASA.

Full LYSFF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this LYSFF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LYSFF vs SCHDLYSFF vs JEPILYSFF vs OLYSFF vs KOLYSFF vs MAINLYSFF vs JNJLYSFF vs ABBVLYSFF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.